MAPK3 and colorectal cancer: Figure 7a confirms the data of the phospho-MAPK assay by Western blot in which we also saw that treatment with the IC50 of C19 for 24 h significantly inhibited the phosphorylation of Erk1/2 in both colorectal cancer cell lines.